British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...